Calumet, Inc. (NASDAQ:CLMT – Get Free Report) major shareholder Group Heritage sold 626,998 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $32.54, for a total transaction of $20,402,514.92. Following the sale, the insider directly owned 12,980,211 shares of the company’s stock, valued at $422,376,065.94. This represents a 4.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Calumet Stock Down 0.4%
Shares of NASDAQ CLMT traded down $0.12 during trading on Tuesday, hitting $32.23. 708,794 shares of the company traded hands, compared to its average volume of 1,329,058. Calumet, Inc. has a 1 year low of $12.70 and a 1 year high of $36.94. The company has a 50-day moving average price of $31.85 and a 200-day moving average price of $25.32. The firm has a market capitalization of $2.81 billion, a P/E ratio of -14.92 and a beta of 0.72.
Calumet (NASDAQ:CLMT – Get Free Report) last announced its quarterly earnings data on Friday, May 8th. The oil and gas company reported ($3.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($3.31). The firm had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1 billion. During the same period in the previous year, the company earned ($1.87) earnings per share. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. Research analysts predict that Calumet, Inc. will post -0.31 EPS for the current fiscal year.
Hedge Funds Weigh In On Calumet
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the stock. TD Cowen lifted their target price on shares of Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, March 5th. HC Wainwright lifted their target price on shares of Calumet from $33.00 to $60.00 and gave the company a “buy” rating in a report on Monday, March 30th. The Goldman Sachs Group lowered shares of Calumet from a “buy” rating to a “neutral” rating and set a $36.00 target price on the stock. in a report on Friday, April 24th. UBS Group restated a “neutral” rating and set a $26.00 target price on shares of Calumet in a report on Friday, February 13th. Finally, Weiss Ratings upgraded shares of Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Calumet has a consensus rating of “Hold” and a consensus price target of $36.75.
Check Out Our Latest Stock Report on Calumet
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Read More
- Five stocks we like better than Calumet
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
